Skip to content

Comparison of Standard and Minidose Spinal Anesthesia for Cesarean Section Operation Using Marcaine Spinal 0.5% Heavy

Phase IV, Randomized, Parallel Designed, Single Blinded Study, Comparing the Standard and Minidose Spinal Anesthesia Using Marcaine Spinal 0.5% Heavy With Addition of Fentanyl During Cesarean Section

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01303731
Enrollment
100
Registered
2011-02-25
Start date
2011-02-28
Completion date
2012-01-31
Last updated
2011-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section, Anesthesia, Spinal, Local Anaesthetics Causing Adverse Effects in Therapeutic Use

Keywords

Spinal anesthesia, Cesarean section, Marcaine Spinal 0.5% Heavy minidose, Fentanyl, Local Anesthetics

Brief summary

The objectives of this study is to test a combination of low dose local anesthetic Bupivacaine diluted in patient's CSF with lipophilic opiate Fentanyl for optimal spinal anesthesia during Cesarean Section. The dilution of Bupivacaine with CSF in our study would result in effective spinal anesthesia with relatively limited motor block, quick recovery of motor function and relatively long lasting analgesia. We expect lower incidence of side effects with this combination than with convenient dose of Bupivacaine.

Detailed description

Spinal anesthesia is the most frequent type of anesthesia used for Cesarian Section. However, despite decades of safe utilization there is still controversy about the best combination of local anesthetics and additives needed to obtain the optimal result. The objectives of this study is to test a combination of low dose local anesthetic Bupivacaine diluted in patient's CSF with lipophilic opiate Fentanyl for compliance with the criteria of optimal spinal anesthesia. Bupivacaine is the most frequently used local anesthetic in the last twenty years . It characterized by fast onset, high potency and long action . Albeit this is intrinsic characteristic of specific local anesthetic, its manifestation can be affected by concentration. It has been shown that dilution of local anesthetic with CSF can result in sensory block with less profound motor block. Thus dilution of Bupivacaine with CSF in our study would serve double function: it would speed the recovery from the spinal anesthesia and minimize the expression of the motor block.Addition of opiates to local anesthetics has been widely used . It has been shown that this addition improves quality of spinal anesthesia and prolongs analgesia without significant prolongation of recovery from motor block. In summary, we would use well known safe local anesthetic Bupivacaine in low dose and low concentration (after dilution with patient's CSF) in conjunction with highly lipophilic opiate Fentanyl. We suppose it will result in effective spinal anesthesia with relatively limited motor block, quick recovery of motor function and relatively long lasting analgesia. We expect lower incidence of side effect with this combination than with convenient dose of Bupivacaine. Good pain relief and swift restoration of ability to ambulate will be important for prevention of postoperative complications, will diminish the need for systemic analgetic drugs that can affect nursing and will increase patients' satisfaction.

Interventions

Spinal anesthesia with Marcaine Spinal 0.5% Heavy 7.5 mg (1.5 ml) diluted in 0.75ml of patient's CSF (0.25 ml)with addition of Fentanyl 12.5 mcg (total 2.5 ml)

DRUGBupivacaine

Spinal anesthesia with Marcaine Spinal 0.5% Heavy 12.5 mg (2.5 ml)

Sponsors

Bnai Zion Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Women over 38 weeks of pregnancy, who read and write Hebrew * ASA class I and II * Age between 18 and 40 years * Weight 50-100 kg * Elective Cesarean Section for singlet pregnancy

Exclusion criteria

* Previous history of two or more Cesarean Sections * Contraindications for regional anesthesia * Active pain before surgery * Non singlet pregnancy

Design outcomes

Primary

MeasureTime frameDescription
prominence of motor blockadeup to 2 hAt the begining of the surgery and at the entry of the patients to PACU motor block will be evaluated

Secondary

MeasureTime frameDescription
operative conditionup to 1 hUpon completion of surgery attending surgeon will be asked to rate the operative condition.
intraoperative hypotensionup to 1 hNumber of treatments for hypotensions during the surgery will be monitored.
need for postoperative pain medicationup to 2 hThe pain or discomfort intensity during the surgery, and at PACU will be graded.
general patient satisfactionafter 24 hOn the next day, all patients will be asked to rate their satisfaction following the anesthesia.

Countries

Israel

Contacts

Primary ContactBoris Yanovsky, MD
boris.yanovsky@b-z.org.il+972 50 626788

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026